drugset / Trial / NCT01826175

Comparison of Ticagrelor Versus Clopidogrel on Residual Thrombus Burden During PCI: an OCT Study

NCT01826175 ↗

RandomizedParallel-groupSingle-blind

Summary

Subjects with acute coronary syndromes scheduled for cardiac catheterization will be enrolled in this study. Subjects that are to be treated clinically with coronary artery stenting will be randomized to receive a loading dose of clopidogrel versus ticagrelor after diagnostic angiography but prior to stenting. Optical coherence tomography (OCT) will be performed after stenting and the presence of blood clots inside the new stent will be measured and compared between the groups.

Timeline

Start
2013-05
Primary completion
2014-05
Completion
2014-05

Outcome

Outcome not reported

Stopped (Enrollment): “Study terminated mutually by sponsor \& PI due to no enrollment”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clopidogrel Small molecule 600 mg —
Subject Ticagrelor Small molecule 180 mg —